• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy for HPV associated cancer.

作者信息

Frazer Ian H, Chandra Janin

机构信息

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, 4102, Australia.

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, 4102, Australia.

出版信息

Papillomavirus Res. 2019 Dec;8:100176. doi: 10.1016/j.pvr.2019.100176. Epub 2019 Jul 13.

DOI:10.1016/j.pvr.2019.100176
PMID:31310819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6639647/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c920/6639647/3989077ce64a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c920/6639647/3989077ce64a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c920/6639647/3989077ce64a/gr1.jpg

相似文献

1
Immunotherapy for HPV associated cancer.人乳头瘤病毒相关癌症的免疫疗法。
Papillomavirus Res. 2019 Dec;8:100176. doi: 10.1016/j.pvr.2019.100176. Epub 2019 Jul 13.
2
Acute exercise does not improve immune response to HPV vaccination series in adolescents.急性运动并不能改善青少年对人乳头瘤病毒（HPV）疫苗系列接种的免疫反应。
Papillomavirus Res. 2019 Dec;8:100178. doi: 10.1016/j.pvr.2019.100178. Epub 2019 Jul 15.
3
Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.联合溶瘤 MG1-E6E7 进行肽疫苗接种的 HPV 相关癌症的临床前开发。
Vaccine. 2018 Apr 12;36(16):2181-2192. doi: 10.1016/j.vaccine.2018.02.070. Epub 2018 Mar 12.
4
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.纳米抗体-抗原偶联物诱导 HPV 特异性抗肿瘤免疫应答。
Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23.
5
Immune evasion mechanisms of human papillomavirus: An update.人乳头瘤病毒的免疫逃逸机制：最新进展
Int J Cancer. 2018 Jan 15;142(2):224-229. doi: 10.1002/ijc.31027. Epub 2017 Sep 13.
6
The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.TLRs 介导的 HPV 病毒调控机制及其相关 HPV 相关性癌症的治疗方法。
Front Immunol. 2024 May 15;15:1407649. doi: 10.3389/fimmu.2024.1407649. eCollection 2024.
7
hrHPV E5 oncoprotein: immune evasion and related immunotherapies.人乳头瘤病毒16型E5癌蛋白：免疫逃逸及相关免疫疗法
J Exp Clin Cancer Res. 2017 May 25;36(1):71. doi: 10.1186/s13046-017-0541-1.
8
Prevalence of human papillomavirus antibodies in young female subjects in England.英国年轻女性人群中人乳头瘤病毒抗体的流行情况
Br J Cancer. 2007 Oct 8;97(7):989-91. doi: 10.1038/sj.bjc.6603955. Epub 2007 Aug 28.
9
Customized Viral Immunotherapy for HPV-Associated Cancer.定制病毒免疫疗法治疗 HPV 相关癌症。
Cancer Immunol Res. 2017 Oct;5(10):847-859. doi: 10.1158/2326-6066.CIR-17-0102. Epub 2017 Sep 14.
10
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.调节 HPV 感染和 HPV 导向免疫治疗期间的免疫反应。
Immunol Rev. 2011 Jan;239(1):85-98. doi: 10.1111/j.1600-065X.2010.00966.x.

引用本文的文献

1
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer.持续性病原体感染与肿瘤微环境和癌症免疫治疗的相互作用。
Cancer Med. 2024 Sep;13(17):e70154. doi: 10.1002/cam4.70154.
2
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.一项Ib期研究，评估人乳头瘤病毒DNA疫苗（AMV002）联合度伐利尤单抗用于人乳头瘤病毒相关口咽鳞状细胞癌的安全性。
Front Oncol. 2024 Jul 5;14:1419258. doi: 10.3389/fonc.2024.1419258. eCollection 2024.
3
Vitamin D3 (Calcitriol) Monotherapy Decreases Tumor Growth, Increases Survival, and Correlates with Low Neutrophil-to-Lymphocyte Ratio in a Murine HPV-16-Related Cancer Model.

本文引用的文献

1
HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development.HPV16 E7 驱动的上皮细胞增生促进抗原呈递受损和调节性 T 细胞发育障碍。
J Invest Dermatol. 2019 Dec;139(12):2467-2476.e3. doi: 10.1016/j.jid.2019.03.1162. Epub 2019 Jun 15.
2
Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma.调节性 T 细胞和 M2 极化的肿瘤相关巨噬细胞与口腔鳞状细胞癌的发生和进展有关。
Int J Oral Maxillofac Surg. 2019 Oct;48(10):1279-1288. doi: 10.1016/j.ijom.2019.04.004. Epub 2019 May 1.
3
在小鼠人乳头瘤病毒16型相关癌症模型中，维生素D3（骨化三醇）单一疗法可降低肿瘤生长、提高生存率，并与低中性粒细胞与淋巴细胞比值相关。
Biomedicines. 2024 Jun 18;12(6):1357. doi: 10.3390/biomedicines12061357.
4
Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine.非侵入性采集首段尿液中生物标志物的浓度策略：有标记和自然存在的生物标志物。
Eur J Med Res. 2024 Feb 17;29(1):131. doi: 10.1186/s40001-024-01719-5.
5
Monoclonal antibodies in cervical malignancy-related HPV.宫颈癌相关人乳头瘤病毒中的单克隆抗体。
Front Oncol. 2022 Oct 6;12:904790. doi: 10.3389/fonc.2022.904790. eCollection 2022.
6
Emerging Trends in the Pathological Research of Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒阳性口咽鳞状细胞癌病理研究的新趋势
J Clin Transl Pathol. 2022;2(2):31-36. doi: 10.14218/jctp.2022.00004. Epub 2022 Apr 1.
7
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.肿瘤细胞外在突触连蛋白 3 表达作为头颈部癌症的诊断和预后生物标志物。
Cancer Res Commun. 2022 Sep;2(9):987-1004. doi: 10.1158/2767-9764.crc-21-0135. Epub 2022 Sep 15.
8
Modeling and Mathematical Analysis of the Dynamics of HPV in Cervical Epithelial Cells: Transient, Acute, Latency, and Chronic Infections.HPV 病毒在宫颈上皮细胞中的动力学建模与数学分析：瞬时感染、急性感染、潜伏感染和慢性感染。
Comput Math Methods Med. 2022 Aug 23;2022:8650071. doi: 10.1155/2022/8650071. eCollection 2022.
9
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.人乳头瘤病毒相关性口咽癌：流行病学、分子生物学及临床管理。
Nat Rev Clin Oncol. 2022 May;19(5):306-327. doi: 10.1038/s41571-022-00603-7. Epub 2022 Feb 1.
10
Cancer Microbiology.癌症微生物学。
J Natl Cancer Inst. 2022 May 9;114(5):651-663. doi: 10.1093/jnci/djab212.
Genetic susceptibility to cervical neoplasia.
宫颈癌变的遗传易感性。
Papillomavirus Res. 2019 Jun;7:132-134. doi: 10.1016/j.pvr.2019.04.002. Epub 2019 Apr 5.
4
The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.检查点抑制对头颈部鳞状细胞癌的影响：系统评价。
Oral Oncol. 2019 Mar;90:67-73. doi: 10.1016/j.oraloncology.2019.01.018. Epub 2019 Feb 5.
5
PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives.PD-1/PD-L1 阻断在宫颈癌中的应用：当前的研究和展望。
Front Med. 2019 Aug;13(4):438-450. doi: 10.1007/s11684-018-0674-4. Epub 2019 Mar 2.
6
Cervical Cancer-Instructed Stromal Fibroblasts Enhance IL23 Expression in Dendritic Cells to Support Expansion of Th17 Cells.宫颈癌指导的基质成纤维细胞增强树突状细胞中 IL23 的表达以支持 Th17 细胞的扩增。
Cancer Res. 2019 Apr 1;79(7):1573-1586. doi: 10.1158/0008-5472.CAN-18-1913. Epub 2019 Jan 29.
7
Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.招募抗原呈递细胞到 HPV16E7 表达皮肤的引流淋巴结需要 E7-Rb 相互作用。
Front Immunol. 2018 Dec 18;9:2896. doi: 10.3389/fimmu.2018.02896. eCollection 2018.
8
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.联合免疫检查点阻断和肿瘤特异性疫苗治疗不可治愈的人乳头瘤病毒 16 型相关癌症患者：一项 2 期临床试验。
JAMA Oncol. 2019 Jan 1;5(1):67-73. doi: 10.1001/jamaoncol.2018.4051.
9
Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies.抗 PD-1/PD-L1 治疗非小细胞肺癌：迈向个体化医学和联合策略。
J Immunol Res. 2018 Aug 8;2018:6984948. doi: 10.1155/2018/6984948. eCollection 2018.
10
Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.表达鼠源人乳头瘤病毒16型E7的转基因皮肤能有效模拟人类高级别鳞状上皮内病变的细胞和分子特征。
Papillomavirus Res. 2018 Jun;5:6-20. doi: 10.1016/j.pvr.2017.10.001. Epub 2017 Oct 19.